
Sign up to save your podcasts
Or


This week, hosts Anthony Cruz and Mark Ambrogio are joined by Milan Mammen, a first-year master's student in Western's department of biochemistry. Milan's research focuses on how nonsense suppressor tRNAs may be used to treat Duchenne Muscular Dystrophy (DMD), a severe type of muscular dystrophy that has severe negative impacts on a person's movement capabilities. Listen to learn more about Milan's research!
Recorded on Tuesday, October 14, 2025.
By Maris Schneider, Anthony Cruz, Mark Ambrogio, Scott Walters, Ryan Baxter, Maria Khan, Garth Casbourn, Riya Sidhu, Sarah Bidinosti, Chrishma Perera, Bruno Mesquita, Kirstyn Seanor, Mohammed ZerattiThis week, hosts Anthony Cruz and Mark Ambrogio are joined by Milan Mammen, a first-year master's student in Western's department of biochemistry. Milan's research focuses on how nonsense suppressor tRNAs may be used to treat Duchenne Muscular Dystrophy (DMD), a severe type of muscular dystrophy that has severe negative impacts on a person's movement capabilities. Listen to learn more about Milan's research!
Recorded on Tuesday, October 14, 2025.